Changing Treatment for CLL and Non-Hodgkin's Lymphoma

EP. 1: Introduction: Upfront Treatment in Patients With CLL

January 16th 2015

EP. 2: First-Line Treatment Selection in CLL

January 16th 2015

EP. 3: Safety and Efficacy of Obinutuzumab in CLL

January 16th 2015

EP. 4: Optimizing Treatment With Ibrutinib in High-Risk CLL

January 16th 2015

EP. 5: Role of Transplantation in High-Risk CLL

January 16th 2015

EP. 6: Maintenance Therapy in Chronic Lymphocytic Leukemia

January 16th 2015

EP. 7: Strategies for Managing Immune Thrombocytopenia in CLL

January 16th 2015

EP. 8: Novel Treatment Approaches to Relapsed/Refractory CLL

January 16th 2015

EP. 9: Role of NOTCH1 Mutations in CLL

January 16th 2015

EP. 10: Assessing Response With Novel Agents in CLL

January 16th 2015

EP. 11: Indolent Non-Hodgkin's Lymphoma Treatment Selection

January 16th 2015

EP. 12: Translating Novel CLL Therapies to Other Types of NHL

January 16th 2015

EP. 13: Improving Outcomes in Mantle Cell Lymphoma

January 16th 2015

EP. 14: Utility of MRD in Mantle Cell Lymphoma

January 16th 2015

EP. 15: Strategies for Treating Myc-Positive DLBCL

January 16th 2015

EP. 16: Treatments and Phenotypes in DLBCL

January 16th 2015

EP. 17: Closing Thoughts: A Cure in Sight for CLL?

January 16th 2015